Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications
Frontiers in Pharmacology · 2025-11-27 · 16
DOI: 10.3389/fphar.2025.1711653 ↗At a glance
Übersichtsarbeit in Frontiers in Pharmacology, published online on 2025-11-27. Written by Mahewish Sayyad and 4 co-authors. Institution: Department of Biotechnology, Priyadarshini College of Engineering, Nagpur, India. Cited 18 times so far (Crossref); 141 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Silymarin, extracted from the seeds of Silybum marianum (milk thistle), has been utilised in traditional medicine for many years and is recognised for its neuroprotective and hepatoprotective properties. Existing research reveals that silymarin has potent antioxidant and anti-inflammatory effects, coupled with anti-fibrotic, anti-carcinogenic, neuro-regenerative, and immunomodulatory actions, and has broad therapeutic relevance in both neurological and hepatic disorders, albeit with the drawback of low solubility. Silymarin participates in multiple molecular and cellular pathways to show its therapeutic effect. Nanocarriers are a promising solution to silymarin’s low solubility and limited bioavailability, aiming to enhance targeted delivery to the central nervous system and hepatic tissue. These developments position silymarin as a multi-domain phytopharmaceutical with significant translational potential. This review provides an overview of silymarin’s historical context, phytochemical composition, and pharmacokinetic profile, with a particular focus on targeted drug delivery systems. Special emphasis is placed on its potential role in managing various diseases.
Subjects
Author keywords
Authors and institutions
- Department of Biotechnology, Priyadarshini College of Engineering, Nagpur, India.
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER, Raebareli), Raebareli, India.
- Department of Pharmacy, Era Medical College and University, Lucknow, India.
Cite
APA
Sayyad, M., Sutar, A. D., Shivhare, K., Shukla, R., & Flora, S. J. S. (2025). Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1711653
Vancouver
Sayyad M, Sutar AD, Shivhare K, Shukla R, Flora SJS. Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1711653
BibTeX
@article{Sayyad2025,
author = {Sayyad, Mahewish and Sutar, Ashish Dilip and Shivhare, Kamini and Shukla, Rahul and Flora, Swaran J S},
title = {Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1711653}
}
EUVIMED